HEADER HYDROLASE 16-MAY-16 5JZB TITLE CRYSTAL STRUCTURE OF HSAD BOUND TO 3,5-DICHLOROBENZENE SULPHONAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 4,5:9,10-DISECO-3-HYDROXY-5,9,17-TRIOXOANDROSTA-1(10),2- COMPND 3 DIENE-4-OATE HYDROLASE; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: HSAD; COMPND 6 SYNONYM: 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDROLASE,HOPDA COMPND 7 HYDROLASE,META-CLEAVAGE PRODUCT HYDROLASE,MCP HYDROLASE; COMPND 8 EC: 3.7.1.17,3.7.1.8; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS (STRAIN ATCC 25618 / SOURCE 3 H37RV); SOURCE 4 ORGANISM_TAXID: 83332; SOURCE 5 GENE: HSAD, BPHD, RV3569C; SOURCE 6 EXPRESSION_SYSTEM: PSEUDOMONAS PUTIDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 303; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: KT2442; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVLT31 KEYWDS HSAD, M. TUBERCULOSIS, CHOLESTEROL, INHIBITOR, MCP-HYDROLASE, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.RYAN,E.POLYCARPOU,N.A.LACK,D.EVANGELOPOULOS,C.SIEG,A.HALMAN, AUTHOR 2 S.BHAKTA,A.SINCLAIR,O.ELEFTHERIADOU,T.D.MCHUGH,S.KEANY,E.LOWE, AUTHOR 3 R.BALLET,A.ABIHAMMAD,A.CIULLI,E.SIM REVDAT 4 08-MAY-24 5JZB 1 REMARK ATOM REVDAT 3 05-JUL-17 5JZB 1 JRNL REVDAT 2 12-APR-17 5JZB 1 JRNL REVDAT 1 05-APR-17 5JZB 0 JRNL AUTH A.RYAN,E.POLYCARPOU,N.A.LACK,D.EVANGELOPOULOS,C.SIEG, JRNL AUTH 2 A.HALMAN,S.BHAKTA,O.ELEFTHERIADOU,T.D.MCHUGH,S.KEANY, JRNL AUTH 3 E.D.LOWE,R.BALLET,A.ABUHAMMAD,W.R.JACOBS,A.CIULLI,E.SIM JRNL TITL INVESTIGATION OF THE MYCOBACTERIAL ENZYME HSAD AS A JRNL TITL 2 POTENTIAL NOVEL TARGET FOR ANTI-TUBERCULAR AGENTS USING A JRNL TITL 3 FRAGMENT-BASED DRUG DESIGN APPROACH. JRNL REF BR. J. PHARMACOL. V. 174 2209 2017 JRNL REFN ISSN 1476-5381 JRNL PMID 28380256 JRNL DOI 10.1111/BPH.13810 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 38698 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1939 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 50.9103 - 5.0639 1.00 2795 143 0.1886 0.2251 REMARK 3 2 5.0639 - 4.0199 1.00 2678 152 0.1685 0.1830 REMARK 3 3 4.0199 - 3.5119 1.00 2632 150 0.1921 0.2229 REMARK 3 4 3.5119 - 3.1908 1.00 2627 144 0.2111 0.2452 REMARK 3 5 3.1908 - 2.9622 1.00 2621 142 0.2199 0.2313 REMARK 3 6 2.9622 - 2.7875 1.00 2639 123 0.2270 0.2785 REMARK 3 7 2.7875 - 2.6479 1.00 2615 117 0.2249 0.2712 REMARK 3 8 2.6479 - 2.5327 1.00 2598 145 0.2272 0.2712 REMARK 3 9 2.5327 - 2.4352 1.00 2618 134 0.2195 0.2343 REMARK 3 10 2.4352 - 2.3512 1.00 2550 154 0.2219 0.2734 REMARK 3 11 2.3512 - 2.2776 1.00 2635 124 0.2289 0.2368 REMARK 3 12 2.2776 - 2.2125 1.00 2562 147 0.2256 0.2521 REMARK 3 13 2.2125 - 2.1543 1.00 2614 125 0.2465 0.3034 REMARK 3 14 2.1543 - 2.1017 1.00 2575 139 0.2613 0.3039 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.600 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 4498 REMARK 3 ANGLE : 1.277 6099 REMARK 3 CHIRALITY : 0.057 656 REMARK 3 PLANARITY : 0.007 799 REMARK 3 DIHEDRAL : 15.255 1627 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 10.3650 -11.1316 22.7862 REMARK 3 T TENSOR REMARK 3 T11: 0.2138 T22: 0.2811 REMARK 3 T33: 0.2607 T12: -0.0467 REMARK 3 T13: -0.0142 T23: -0.0322 REMARK 3 L TENSOR REMARK 3 L11: 1.6785 L22: 1.2771 REMARK 3 L33: 0.4511 L12: 0.3025 REMARK 3 L13: -0.2573 L23: 0.0908 REMARK 3 S TENSOR REMARK 3 S11: -0.0206 S12: -0.6397 S13: 0.2117 REMARK 3 S21: -0.2955 S22: -0.0226 S23: -0.1286 REMARK 3 S31: -0.1054 S32: 0.1765 S33: 0.1943 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5JZB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAY-16. REMARK 100 THE DEPOSITION ID IS D_1000221467. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-FEB-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97630 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38700 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.13400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : 0.46900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% (W/V) PEG-3000, 0.1M CHES PH 9.5, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y,-Z REMARK 290 8555 X,-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.01500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 97.12500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.16500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 97.12500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.01500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.16500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 41.01500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.16500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 97.12500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.16500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 41.01500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 97.12500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -41.16500 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 455 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 464 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU B 7 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 10 CG CD OE1 OE2 REMARK 480 GLU A 17 CG CD OE1 OE2 REMARK 480 LYS A 25 CD CE NZ REMARK 480 GLN A 37 CG CD OE1 NE2 REMARK 480 LYS A 81 NZ REMARK 480 ARG A 107 CZ NH1 NH2 REMARK 480 LYS A 160 CD CE NZ REMARK 480 GLU A 168 CG CD OE1 OE2 REMARK 480 LYS A 181 NZ REMARK 480 LYS A 210 CE NZ REMARK 480 GLU B 10 CG CD OE1 OE2 REMARK 480 LYS B 25 CD CE NZ REMARK 480 ASP B 36 CG OD1 OD2 REMARK 480 LYS B 160 CD CE NZ REMARK 480 GLU B 168 CD OE1 OE2 REMARK 480 LYS B 181 CE NZ REMARK 480 GLN B 191 CD OE1 NE2 REMARK 480 LYS B 210 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 192 O HOH A 401 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 58 -40.97 -135.30 REMARK 500 LYS A 81 76.46 -117.82 REMARK 500 HIS A 85 148.92 173.02 REMARK 500 SER A 114 -112.76 51.55 REMARK 500 MET A 221 59.66 -96.78 REMARK 500 LYS B 81 77.89 -119.55 REMARK 500 HIS B 85 149.17 166.87 REMARK 500 SER B 114 -111.40 43.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6OT A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6OT B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2VF2 RELATED DB: PDB REMARK 900 APO ENZYME REMARK 900 RELATED ID: 5JZ9 RELATED DB: PDB REMARK 900 ENZYME WITH A DIFFERENT INHIBITOR DBREF 5JZB A 7 288 UNP P9WNH5 HSAD_MYCTU 7 288 DBREF 5JZB B 7 288 UNP P9WNH5 HSAD_MYCTU 7 288 SEQRES 1 A 282 LEU THR PHE GLU SER THR SER ARG PHE ALA GLU VAL ASP SEQRES 2 A 282 VAL ASP GLY PRO LEU LYS LEU HIS TYR HIS GLU ALA GLY SEQRES 3 A 282 VAL GLY ASN ASP GLN THR VAL VAL LEU LEU HIS GLY GLY SEQRES 4 A 282 GLY PRO GLY ALA ALA SER TRP THR ASN PHE SER ARG ASN SEQRES 5 A 282 ILE ALA VAL LEU ALA ARG HIS PHE HIS VAL LEU ALA VAL SEQRES 6 A 282 ASP GLN PRO GLY TYR GLY HIS SER ASP LYS ARG ALA GLU SEQRES 7 A 282 HIS GLY GLN PHE ASN ARG TYR ALA ALA MET ALA LEU LYS SEQRES 8 A 282 GLY LEU PHE ASP GLN LEU GLY LEU GLY ARG VAL PRO LEU SEQRES 9 A 282 VAL GLY ASN SER LEU GLY GLY GLY THR ALA VAL ARG PHE SEQRES 10 A 282 ALA LEU ASP TYR PRO ALA ARG ALA GLY ARG LEU VAL LEU SEQRES 11 A 282 MET GLY PRO GLY GLY LEU SER ILE ASN LEU PHE ALA PRO SEQRES 12 A 282 ASP PRO THR GLU GLY VAL LYS ARG LEU SER LYS PHE SER SEQRES 13 A 282 VAL ALA PRO THR ARG GLU ASN LEU GLU ALA PHE LEU ARG SEQRES 14 A 282 VAL MET VAL TYR ASP LYS ASN LEU ILE THR PRO GLU LEU SEQRES 15 A 282 VAL ASP GLN ARG PHE ALA LEU ALA SER THR PRO GLU SER SEQRES 16 A 282 LEU THR ALA THR ARG ALA MET GLY LYS SER PHE ALA GLY SEQRES 17 A 282 ALA ASP PHE GLU ALA GLY MET MET TRP ARG GLU VAL TYR SEQRES 18 A 282 ARG LEU ARG GLN PRO VAL LEU LEU ILE TRP GLY ARG GLU SEQRES 19 A 282 ASP ARG VAL ASN PRO LEU ASP GLY ALA LEU VAL ALA LEU SEQRES 20 A 282 LYS THR ILE PRO ARG ALA GLN LEU HIS VAL PHE GLY GLN SEQRES 21 A 282 CYS GLY HIS TRP VAL GLN VAL GLU LYS PHE ASP GLU PHE SEQRES 22 A 282 ASN LYS LEU THR ILE GLU PHE LEU GLY SEQRES 1 B 282 LEU THR PHE GLU SER THR SER ARG PHE ALA GLU VAL ASP SEQRES 2 B 282 VAL ASP GLY PRO LEU LYS LEU HIS TYR HIS GLU ALA GLY SEQRES 3 B 282 VAL GLY ASN ASP GLN THR VAL VAL LEU LEU HIS GLY GLY SEQRES 4 B 282 GLY PRO GLY ALA ALA SER TRP THR ASN PHE SER ARG ASN SEQRES 5 B 282 ILE ALA VAL LEU ALA ARG HIS PHE HIS VAL LEU ALA VAL SEQRES 6 B 282 ASP GLN PRO GLY TYR GLY HIS SER ASP LYS ARG ALA GLU SEQRES 7 B 282 HIS GLY GLN PHE ASN ARG TYR ALA ALA MET ALA LEU LYS SEQRES 8 B 282 GLY LEU PHE ASP GLN LEU GLY LEU GLY ARG VAL PRO LEU SEQRES 9 B 282 VAL GLY ASN SER LEU GLY GLY GLY THR ALA VAL ARG PHE SEQRES 10 B 282 ALA LEU ASP TYR PRO ALA ARG ALA GLY ARG LEU VAL LEU SEQRES 11 B 282 MET GLY PRO GLY GLY LEU SER ILE ASN LEU PHE ALA PRO SEQRES 12 B 282 ASP PRO THR GLU GLY VAL LYS ARG LEU SER LYS PHE SER SEQRES 13 B 282 VAL ALA PRO THR ARG GLU ASN LEU GLU ALA PHE LEU ARG SEQRES 14 B 282 VAL MET VAL TYR ASP LYS ASN LEU ILE THR PRO GLU LEU SEQRES 15 B 282 VAL ASP GLN ARG PHE ALA LEU ALA SER THR PRO GLU SER SEQRES 16 B 282 LEU THR ALA THR ARG ALA MET GLY LYS SER PHE ALA GLY SEQRES 17 B 282 ALA ASP PHE GLU ALA GLY MET MET TRP ARG GLU VAL TYR SEQRES 18 B 282 ARG LEU ARG GLN PRO VAL LEU LEU ILE TRP GLY ARG GLU SEQRES 19 B 282 ASP ARG VAL ASN PRO LEU ASP GLY ALA LEU VAL ALA LEU SEQRES 20 B 282 LYS THR ILE PRO ARG ALA GLN LEU HIS VAL PHE GLY GLN SEQRES 21 B 282 CYS GLY HIS TRP VAL GLN VAL GLU LYS PHE ASP GLU PHE SEQRES 22 B 282 ASN LYS LEU THR ILE GLU PHE LEU GLY HET 6OT A 301 17 HET PO4 A 302 5 HET 6OT B 301 17 HETNAM 6OT 3,5-DICHLOROBENZENE-1-SULFONAMIDE HETNAM PO4 PHOSPHATE ION FORMUL 3 6OT 2(C6 H5 CL2 N O2 S) FORMUL 4 PO4 O4 P 3- FORMUL 6 HOH *107(H2 O) HELIX 1 AA1 THR A 8 THR A 12 1 5 HELIX 2 AA2 ALA A 50 PHE A 55 1 6 HELIX 3 AA3 ASN A 58 ALA A 63 1 6 HELIX 4 AA4 GLN A 87 GLY A 104 1 18 HELIX 5 AA5 SER A 114 TYR A 127 1 14 HELIX 6 AA6 THR A 152 ALA A 164 1 13 HELIX 7 AA7 THR A 166 VAL A 176 1 11 HELIX 8 AA8 ASP A 180 ILE A 184 5 5 HELIX 9 AA9 THR A 185 SER A 197 1 13 HELIX 10 AB1 THR A 198 PHE A 212 1 15 HELIX 11 AB2 ASP A 216 LEU A 229 5 14 HELIX 12 AB3 PRO A 245 GLY A 248 5 4 HELIX 13 AB4 ALA A 249 ILE A 256 1 8 HELIX 14 AB5 TRP A 270 LYS A 275 1 6 HELIX 15 AB6 LYS A 275 LEU A 287 1 13 HELIX 16 AB7 PHE B 9 THR B 12 1 4 HELIX 17 AB8 ALA B 50 PHE B 55 1 6 HELIX 18 AB9 ASN B 58 ALA B 63 1 6 HELIX 19 AC1 GLN B 87 GLY B 104 1 18 HELIX 20 AC2 SER B 114 TYR B 127 1 14 HELIX 21 AC3 THR B 152 ALA B 164 1 13 HELIX 22 AC4 THR B 166 VAL B 176 1 11 HELIX 23 AC5 ASP B 180 ILE B 184 5 5 HELIX 24 AC6 THR B 185 SER B 197 1 13 HELIX 25 AC7 THR B 198 PHE B 212 1 15 HELIX 26 AC8 ASP B 216 LEU B 229 5 14 HELIX 27 AC9 PRO B 245 GLY B 248 5 4 HELIX 28 AD1 ALA B 249 ILE B 256 1 8 HELIX 29 AD2 TRP B 270 LYS B 275 1 6 HELIX 30 AD3 LYS B 275 GLY B 288 1 14 SHEET 1 AA1 8 SER A 13 ASP A 19 0 SHEET 2 AA1 8 PRO A 23 ALA A 31 -1 O LEU A 26 N ALA A 16 SHEET 3 AA1 8 HIS A 67 VAL A 71 -1 O ALA A 70 N HIS A 29 SHEET 4 AA1 8 THR A 38 LEU A 42 1 N VAL A 39 O HIS A 67 SHEET 5 AA1 8 VAL A 108 ASN A 113 1 O VAL A 111 N LEU A 42 SHEET 6 AA1 8 ALA A 131 MET A 137 1 O VAL A 135 N GLY A 112 SHEET 7 AA1 8 VAL A 233 GLY A 238 1 O ILE A 236 N LEU A 136 SHEET 8 AA1 8 ALA A 259 PHE A 264 1 O GLN A 260 N LEU A 235 SHEET 1 AA2 8 SER B 13 ASP B 19 0 SHEET 2 AA2 8 PRO B 23 ALA B 31 -1 O LEU B 26 N ALA B 16 SHEET 3 AA2 8 HIS B 67 VAL B 71 -1 O ALA B 70 N HIS B 29 SHEET 4 AA2 8 THR B 38 LEU B 42 1 N VAL B 39 O HIS B 67 SHEET 5 AA2 8 VAL B 108 ASN B 113 1 O VAL B 111 N VAL B 40 SHEET 6 AA2 8 ALA B 131 MET B 137 1 O VAL B 135 N GLY B 112 SHEET 7 AA2 8 VAL B 233 GLY B 238 1 O LEU B 234 N LEU B 134 SHEET 8 AA2 8 ALA B 259 PHE B 264 1 O PHE B 264 N TRP B 237 CISPEP 1 ASP A 150 PRO A 151 0 -2.97 CISPEP 2 ASP B 150 PRO B 151 0 -0.73 SITE 1 AC1 6 SER A 114 LEU A 115 GLY A 140 LEU A 158 SITE 2 AC1 6 ASN A 244 HOH A 454 SITE 1 AC2 4 ARG A 157 LYS A 181 LYS B 156 HOH B 401 SITE 1 AC3 8 GLY B 45 GLY B 46 SER B 114 LEU B 115 SITE 2 AC3 8 GLY B 140 LEU B 158 ASN B 244 HOH B 426 CRYST1 82.030 82.330 194.250 90.00 90.00 90.00 I 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012191 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012146 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005148 0.00000